What does Mirati Therapeutics, Inc. do?

Jun 22 2025 06:29 PM IST
share
Share Via
Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted oncology products, with a market cap of approximately USD 3.98 billion. As of September 2023, it reported net sales of USD 16 million and a net loss of USD 162 million.
Overview:
Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted oncology products, operating within the biotechnology industry and holding a market cap of USD 3,975.27 million.

Financial Snapshot:
Most recent Net Sales: 16 Million (Quarterly Results - Sep 2023)
Most recent Net Profit: -162 Million (Quarterly Results - Sep 2023)
Market cap: USD 3,975.27 Million

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 99.23%
Debt Equity: -1.02
Return on Equity: -76.71%
Price to Book: 4.20

Contact Details:
Address: 9393 Towne Centre Dr Ste 200, SAN DIEGO CA: 92121-3070
Tel: ['1 858 3323410', '1 858 3323562']
Fax: 1 302 6555049
Website: https://www.mirati.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Mirati Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 08:44 AM IST
share
Share Via
Most Read